T. Rowe Price's David Giroux and Wellington Management's Jean Hynes talk value investing, innovation in healthcare, and where they're finding opportunity.
Morningstar experts discuss patient benefits, costs, and planning for healthcare amid accelerating technology.
AQR's Cliff Asness digs into why some multifactor quantitative strategies have been struggling.
Emmanuel Roman asserts his firm's fixed-income edge at the Morningstar Investment Conference.
Sonal Desai, chief investment officer of the Franklin Templeton fixed-income group, says fundamentals in global bond markets are strong.
Primecap’s managers have been here before and have proven adept at taking advantage of such opportunities.
We see the cuts as a directional improvement for investors, but they do not impact our Morningstar Analyst Ratings.
Gold-rated T. Rowe Price New Horizons is Under Review as Henry Ellenbogen is set to depart.
Outflows accelerate in 2018 amid poor performance for this Gold-rated fund.
We see both firms as having similar strengths but no decisions have been made about integrating the families' fund lineups.